Elevated Serum Fibroblast Growth Factor 21 and Associated Metabolic Dysregulation in Polycystic Ovary Syndrome: A Case–Control Study
FGF21 and Metabolic Dysregulation in PCOS
DOI:
https://doi.org/10.38029/babcockuniv.med.j..v8i1.722Keywords:
Polycystic Ovary Syndrome (PCOS);, Fibroblast Growth Factor 21 (FGF21);, Diagnostic Marker, Insulin Resistance, Endocrine DisordersAbstract
Objective: Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder that not only disrupts reproductive function but is also associated with significant metabolic and hepatic disturbances. This case–control study aimed to compare metabolic and liver function parameters between women with PCOS and healthy controls, with a focus on the potential role of fibroblast growth factor 21 (FGF21) as a diagnostic biomarker.
Methods: Participants were selected according to the Rotterdam criteria and included age- and BMI-matched women with PCOS and healthy controls. Fasting blood samples were collected from all subjects to measure serum lipid profiles, liver enzymes, and FGF21 concentrations. Standard enzymatic colorimetric assays were used for lipid measurements, while liver enzymes were determined via spectrophotometric methods. Circulating FGF21 levels were quantified using a commercially available ELISA kit.
Results
PCOS patients exhibited significantly higher serum FGF21 levels (122 ± 42.3 ng/mL) compared to controls (63.5 ± 21.5 ng/mL, p < 0.001). ROC curve analysis identified an optimal FGF21 cutoff value of approximately 87.78 ng/mL, yielding a sensitivity of 91% and specificity of 90% for PCOS diagnosis.
Conclusion
The study reinforces the association of PCOS with distinct metabolic and hepatic abnormalities. The elevated levels of FGF21 in PCOS patients may reflect a compensatory response to metabolic stress and point to its promise as a novel diagnostic marker. These findings highlight the importance of comprehensive metabolic screening in PCOS and may inform future therapeutic approaches.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Raheem TH, Mohammed MJ

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.